🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qing Chang

Qingdao University

ORCID: 0000-0001-7406-8479

Also affiliated with Memorial Sloan Kettering Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade”.

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Cancer Discovery(2016)10.1158/2159-8290.cd-15-1545

N/A

1.0DataRank · unranked

1012 citations

Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto +39 more

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1

Molecular Cell(2022)10.1016/j.molcel.2022.04.034

N/A

0.841DataRank · unranked

23 citations

Radha Mukherjee, Rona Yaeger, Jieun Son, Jianing Xu, Na Na +22 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0.744DataRank · unranked

142 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Nature Communications(2023)10.1038/s41467-022-35592-9

N/A

0.596DataRank · unranked

52 citations

Henry Walch, Jaclyn F. Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck +23 more

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

Nature Cancer(2023)10.1038/s43018-023-00630-y

N/A

0.553DataRank · unranked

39 citations

Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more

KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0994

N/A

0.425DataRank · unranked

16 citations

Jin K. Kim, Chin‐Tung Chen, Chao Wu, Michael R. Marco, Francisco M. Barriga +10 more

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2424286122

N/A

0.382DataRank · unranked

9 citations

Ezra Y. Rosen, Malvika Sharma, M. Dorso, Nicholas Mai, Corina Amor +22 more

Deep brain stimulation of the nucleus basalis of Meynert in severe Alzheimer’s disease

Journal of Alzheimer's Disease Reports(2024)10.1177/25424823241296780

N/A

0.292DataRank · unranked

6 citations

Bin Liu, Guosong Shang, Shuzhen Liu, Zhebin Feng, Haonan Yang +6 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0.241DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Data from INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

10.1158/2159-8290.c.6549415.v1

N/A

0DataRank · unranked

0 citations

Baishan Jiang, Jiaye Guo, Hong Shao, Isabella Del Priore, Qing Chang +20 more

Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

Cancer Research(2021)10.1158/0008-5472.can-20-2929

N/A

0DataRank · unranked

39 citations

Jianan Lin, Nicolas Lecomte, Prathibha Mohan, Gokce Askan, Viraj R. Sanghvi +21 more

Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis

Cell Reports(2021)10.1016/j.celrep.2021.109870

N/A

0DataRank · unranked

39 citations

Loredana Moro, Rui Qu, Daniele Simoneschi, Hyunwoo Cho, Shaowen Jiang +6 more

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.14.464262

N/A

0DataRank · unranked

0 citations

Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng +19 more

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010

N/A

0DataRank · unranked

113 citations

Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina +9 more

Targeting Tumor Microenvironment–Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0505

N/A

0DataRank · unranked

0 citations

Young Sun Lee, Ninghui Mao, Nazifa Salsabeel, Zeda Zhang, Harshaminder Kaur +7 more

Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.246926

N/A

0DataRank · unranked

9 citations

Milan Grkovski, Isabella O’Donoghue, Teja Kalidindi, Nagavarakishore Pillarsetty, Eva Burnazi +8 more